Kimryn Rathmell

May 10, 2018

Grant bolsters kidney cancer immunotherapy research

W. Kimryn Rathmell, MD, PhD, Cornelius Abernathy Craig Professor of Medicine and director of the Division of Hematology and Oncology at Vanderbilt-Ingram Cancer Center (VICC), has received a grant to research the role of immunosuppression in the tumor microenvironment for kidney cancer.

By Doug Campbell
May 3, 2018

Six Vanderbilt physicians honored by medical societies

Four faculty members of Vanderbilt University School of Medicine were among 78 physician-scientists inducted into The American Society for Clinical Investigation (ASCI), an elite honor society of physician-scientists from the upper ranks of academic medicine and industry. They are:

By Bill Snyder
April 26, 2018

Ware elected VP of clinical investigation society

With last week’s election of Lorraine Ware, MD, as vice president of the American Society for Clinical Investigation (ASCI), two faculty members of the Vanderbilt University School of Medicine are among the current officers of the elite physician-scientist honor society.

By Bill Snyder
close up of blood vessels
March 8, 2018

VICC study sheds new light on Von Hippel-Lindau syndrome

Investigators at Vanderbilt-Ingram Cancer Center (VICC) and the Virginia Tech Carilion Research Institute (VTCRI) have revealed a gene mutation’s role in Von Hippel-Lindau syndrome, a genetically inherited disease which causes tumor growth in several organs.

By VUMC News and Communications
December 19, 2017

Rathmell elected to ASCO nominating committee

W. Kimryn Rathmell, MD, PhD, Cornelius A. Craig Professor of Medicine and director of the Division of Hematology and Oncology at Vanderbilt University Medical Center (VUMC), has been elected to the nominating committee for the American Society of Clinical Oncology (ASCO).

By VUMC News and Communications
September 28, 2017

VU scientists discuss cancer treatments, cellular dynamics

A trio of Vanderbilt University scientists described their cutting-edge investigations of cellular dynamics and cancer treatment during last week’s Flexner Discovery Lecture.

By Leigh MacMillan
August 17, 2017

Kidney cancer patient, survivor event set for Sept. 9

Vanderbilt-Ingram Cancer Center (VICC) will sponsor an educational conference for kidney cancer patients, survivors and family members Saturday, Sept. 9, 8 a.m. – 2 p.m., in the Preston Research Building, Suite 898.
By VUMC News and Communications
April 20, 2017

Vanderbilt’s W. Kimryn Rathmell named to ASCI leadership post

W. Kimryn Rathmell, director of the Division of Hematology/Oncology at Vanderbilt University Medical Center, has been named vice president of The American Society for Clinical Investigation.
By VUMC News and Communications
September 28, 2016

Celebration honors nine endowed chair recipients

Nine faculty members who hold endowed chairs were honored and donors were thanked during a festive celebration Sept. 26 at the Student Life Center.
By VUMC News and Communications
August 18, 2016

VICC helps launch new alliance for rare kidney cancer

Children, adolescents or young adults, particularly African-Americans, diagnosed with advanced kidney cancer may actually have a rare form of the disease known as renal medullary carcinoma (RMC) that requires a specialized approach and expert intervention.
By VUMC News and Communications
May 26, 2016

Precision medicine already changing cancer treatment strategies

The ability to test patients’ cancers for individual differences, mainly at the genetic level, and to make treatment decisions based on those differences is the hallmark of precision medicine, and Vanderbilt University Medical Center (VUMC) is among the leaders of this new approach to diagnosis and treatment.
By VUMC News and Communications
August 13, 2015

Rathmell to direct Division of Hematology and Oncology

W. Kimryn Rathmell, M.D., Ph.D., Alexander Professor for Translational Science and associate director for Training and Education at Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, has been named director of Vanderbilt’s Division of Hematology and Oncology.
By VUMC News and Communications
1 2 3 4